BIHAM receives its first Swiss National Science Foundation (SNSF) grants.
The BIHAM will coordinate two research projects designed to improve clinical practice in colorectal cancer screening, and medication in patients with multiple chronic conditions, both within the framework of the National Research Project (NRP) 74 “Smarter Medicine,” supported by the Swiss National Science Foundation.
Prof. Dr. med Reto Auer and his team received a grant for the study:
“Shared decision making in colorectal cancer screening in primary care: a cluster randomized controlled trial”
- In Switzerland, only one in five people is tested for colon cancer. Many people don’t receive information about testing, and are not aware they can choose between two tests (colonoscopy and stool sample). For example, some don’t get information about screening, some receive only recommendations for colonoscopy, and some are informed about both tests.
- This study will measure screening measure the screening activity of family physicians, who will have the opportunity to discuss their practice and their experiences with their colleagues. Our goal is to increase the proportion of patients who are offered both screening options, and reduce differences in screening techniques across family medicine practices. If all patients are offered both choices, we should see a more even distribution of screening methods across practices.
- The study includes a cross-sectional survey, and a cluster randomized controlled trial. The study will officially begin on 1.4.2017.
Dr. med. Sven Streit, Prof Nicolas Rodondi and their team were awarded a grant for the study:
“Optimising pharmacotherapy in the multimorbid elderly in primary care: a cluster randomized controlled trial"
- Patients with multiple chronic illnesses often take too many medicines, or take medication with inappropriate indications. In daily practice, there is often limited time to systematically examine a patient’s list of medications, and drug interactions may be overlooked. When too many or inappropriate medicines are prescribed, or when patients take medicine incorrectly, health risks and costs increase. Electronic decision-making assistants may help general practitioners (GPs) review medication and limit undesirable side-effects.
- This study will determine if electronic decision-making assistants designed for GPs can increase appropriate prescriptions and improve patient quality of life. There will also be a qualitative component to the research, to determine how GPs integrate the tool into their practices. The study will begin on 1.5.2017.